Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Express Scripts Gets FTC Approval, Closes $29 Bln. Medco Health Acquisition

RELATED NEWS
Trade ESRX now with 

Pharmacy benefit manager Express Scripts Inc. (ESRX: Quote), Monday completed its $29.1 billion acquisition of Medco Health Solutions Inc. (MHS: Quote), after getting the nod from US Federal Trade Commission.

The FTC commissioners voted 3-1 in favor of the merger after reaching a conclusion that the acquisition of Medco by Express Scripts will not change the dynamics in the pharmacy benefit manager (PBM) industry.

On July 21, 2011, Express Scripts agreed to buy Medco Health Solutions for $28.80 in cash plus 0.81 Express Scripts share for each Medco share held. The companies expect the deal to be slightly accretive to earnings, excluding integration and deal-related costs, in the first full year after closing and moderately accretive once fully integrated.

FTC in a statement said, "The commissioners investigation revealed a competitive market for PBM services characterized by numerous, vigorous competitors who are expanding and winning business from traditional market leaders."

FTC also said its investigation revealed that "the merging parties are not particularly close competitors, the market today is not conducive to coordinated interaction, and there is little risk of the merged company exercising monopsony power."

Meanwhile, Julie Brill, the FTC commissioner who dissented, said the $29 billion merger between two of the largest three PBM providers is a "game changer" in the industry and believes the merger to be "a merger-to-duopoly". "This merger will create a highly concentrated market that should be presumed to be likely to enhance market power," she said.

Commissioner Brill has also called on the FTC to conduct a thorough analysis of the industry three years from now to determine "if prices to employers in fact have gone down."

Express Scripts Chief Executive George Paz said, "Our merger is exactly what the country needs now. It represents the next chapter of our mission to lower costs, drive out waste in healthcare and improve patient health."

ESRX is currently trading on the Nasdaq at $56.01, up 3.40%, on a volume of 17.7 million shares, above the three-month average volume of 8.8 million.

Register
To receive FREE breaking news email alerts for Express Scripts Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.